Probable Psychosis Associated With Levetiracetam: A Case Report

被引:0
作者
Aggarwal, Ashish
Sharma, Dinesh Dutt
Sharma, Ravi Chand
Kumar, Ramesh
机构
关键词
REFRACTORY PARTIAL SEIZURES; DOUBLE-BLIND; EPILEPSY; MULTICENTER; CHILDREN; THERAPY; TRIAL;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:E19 / E20
页数:2
相关论文
共 16 条
[1]   Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: A multicenter, double-blind, responder-selected study evaluating monotherapy [J].
Ben-Menachem, E ;
Falter, T .
EPILEPSIA, 2000, 41 (10) :1276-1283
[2]   Levetiracetam for partial seizures - Results of a double-blind, randomized clinical trial [J].
Cereghino, JJ ;
Biton, V ;
Abou-Khalil, B ;
Dreifuss, F ;
Gauer, LJ ;
Leppik, I .
NEUROLOGY, 2000, 55 (02) :236-242
[3]   A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials [J].
Cramer, JA ;
De Rue, K ;
Devinsky, O ;
Edrich, P ;
Trimble, MR .
EPILEPSY & BEHAVIOR, 2003, 4 (02) :124-132
[4]  
Genton P, 2000, EPILEPTIC DISORD, V2, P99
[5]   Levetiracetam psychosis in children with epilepsy [J].
Kossoff, EH ;
Bergey, GK ;
Freeman, JM ;
Vining, EPG .
EPILEPSIA, 2001, 42 (12) :1611-1613
[6]   Long-term continuation of levetiracetam in patients with refractory epilepsy [J].
Krakow, K ;
Walker, M ;
Otoul, C ;
Sander, JWAS .
NEUROLOGY, 2001, 56 (12) :1772-1774
[7]   Suppression of posthypoxic and postencephalitic myoclonus with levetiracetam [J].
Krauss, GL ;
Bergin, A ;
Kramer, RE ;
Cho, YW ;
Reich, SG .
NEUROLOGY, 2001, 56 (03) :411-412
[8]   Psychiatric adverse events during levetiracetam therapy [J].
Mula, M ;
Trimble, MR ;
Yuen, A ;
Liu, RSN ;
Sander, JWAS .
NEUROLOGY, 2003, 61 (05) :704-706
[9]   A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].
NARANJO, CA ;
BUSTO, U ;
SELLERS, EM ;
SANDOR, P ;
RUIZ, I ;
ROBERTS, EA ;
JANECEK, E ;
DOMECQ, C ;
GREENBLATT, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245
[10]   THE NOVEL ANTIEPILEPTIC DRUG LEVETIRACETAM (UCB L059) APPEARS TO ACT VIA A SPECIFIC BINDING-SITE IN CNS MEMBRANES [J].
NOYER, M ;
GILLARD, M ;
MATAGNE, A ;
HENICHART, JP ;
WULFERT, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 286 (02) :137-146